Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Characterizing the Genetic Evolution of Influenza Virus in Ovo

FY 2022-23

Summary
Influenza is one of Canada's most significant public health threats. Our greatest tool to date in combatting the virus is vaccination. However, the most common method of growing Influenza for vaccine production, passage in embryonated chicken eggs (ECEs), causes influenza to adapt to avian host sialic acid receptors --the receptors used by influenza for cell entry, resulting in vaccines made with influenza viruses that may be ill-matched to the strains circulating in human populations. In response to this, mammalian cell-based influenza vaccines have been developed, which theoretically contain viruses that have not undergone adaptation. While on an individual level closely matched vaccines generally confer better immunity, our group has developed a model which suggests that antigenically diverse vaccines produce better levels of population immunity. The goal of this study is to observe the antigenic evolution that occurs both in ECE-based influenza growth and in mammalian cell-based influenza growth, and apply those findings to our population vaccination model. We hypothesize that influenza progeny from ECE propagation will have higher genetic diversity compared to progeny from cell propagation, subsequently conferring greater population immunity. To investigate this, we will follow vaccine propagation protocols for both ECE-based and cell-based vaccines with the WHO recommended vaccine seed viruses for various strains from years 2010-2021. We will observe the growth of influenza through plaque assays. To observe the genetic diversity, we will sequence using the Illumina sequencing platform. The results from this study will provide valuable insight into which types of vaccines are most effective in conferring high levels of population immunity against influenza.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486563
Name
Blais-Savoie Juliette
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the Genetic Evolution of Influenza Virus in Ovo
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Evolution; Influenza; Modeling; Population Immunity; Sequencing; Vaccine
Abstract
Influenza is one of Canada's most significant public health threats. Our greatest tool to date in combatting the virus is vaccination. However, the most common method of growing Influenza for vaccine production, passage in embryonated chicken eggs (ECEs), causes influenza to adapt to avian host sialic acid receptors --the receptors used by influenza for cell entry, resulting in vaccines made with influenza viruses that may be ill-matched to the strains circulating in human populations. In response to this, mammalian cell-based influenza vaccines have been developed, which theoretically contain viruses that have not undergone adaptation. While on an individual level closely matched vaccines generally confer better immunity, our group has developed a model which suggests that antigenically diverse vaccines produce better levels of population immunity. The goal of this study is to observe the antigenic evolution that occurs both in ECE-based influenza growth and in mammalian cell-based influenza growth, and apply those findings to our population vaccination model. We hypothesize that influenza progeny from ECE propagation will have higher genetic diversity compared to progeny from cell propagation, subsequently conferring greater population immunity. To investigate this, we will follow vaccine propagation protocols for both ECE-based and cell-based vaccines with the WHO recommended vaccine seed viruses for various strains from years 2010-2021. We will observe the growth of influenza through plaque assays. To observe the genetic diversity, we will sequence using the Illumina sequencing platform. The results from this study will provide valuable insight into which types of vaccines are most effective in conferring high levels of population immunity against influenza.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Blais-Savoie, Juliette
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~